| |
| |
|
| Insider
Information: |
Adams Brian |
| Relationship: |
|
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
451,836 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,088,166 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
451,836 |
|
|
| Total
Value |
$2,088,166 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
22
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
1
|
21
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
| Percentage
Gain/Loss : |
 -23.6%
|
-723.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Keryx Biopharmaceuticals Inc |
KERX |
General Counsel and Se... |
2018-02-15 |
126,069 |
|
0 |
Premium* |
|
|
Relay Therapeutics, Inc. |
RLAY |
|
2024-04-29 |
325,767 |
2020-07-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
68 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KERX |
Keryx Biopharmaceuticals ... |
General Counsel and Secretary |
• – – |
2017-10-30 |
4 |
S |
$6.03 |
$8,472 |
D/D |
(1,405) |
134,015 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
General Counsel and Secretary |
• – – |
2018-01-05 |
4 |
S |
$4.69 |
$3,532 |
D/D |
(753) |
133,262 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
General Counsel and Secretary |
• – – |
2018-01-29 |
4 |
S |
$4.81 |
$7,412 |
D/D |
(1,541) |
131,721 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
General Counsel and Secretary |
• – – |
2018-02-15 |
4 |
S |
$4.81 |
$27,186 |
D/D |
(5,652) |
126,069 |
0 |
- |
|
| RLAY |
Relay Therapeutics, Inc. |
General Counsel |
• – – |
2020-07-20 |
4 |
B |
$20.00 |
$200,000 |
D/D |
10,000 |
10,000 |
2.74 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
General Counsel |
• – – |
2021-01-28 |
4 |
OE |
$4.12 |
$20,600 |
D/D |
5,000 |
15,000 |
0 |
- |
|
| RLAY |
Relay Therapeutics, Inc. |
General Counsel |
• – – |
2021-01-28 |
4 |
S |
$55.05 |
$275,250 |
D/D |
(5,000) |
10,000 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
General Counsel |
• – – |
2021-03-26 |
4 |
A |
$0.00 |
$0 |
D/D |
15,870 |
25,870 |
0 |
- |
|
| RLAY |
Relay Therapeutics, Inc. |
General Counsel |
• – – |
2021-04-26 |
4 |
AS |
$35.00 |
$227,500 |
D/D |
(6,500) |
25,870 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
General Counsel |
• – – |
2021-04-26 |
4 |
OE |
$4.12 |
$26,780 |
D/D |
6,500 |
32,370 |
0 |
- |
|
| RLAY |
Relay Therapeutics, Inc. |
General Counsel |
• – – |
2021-06-07 |
4 |
OE |
$4.12 |
$26,780 |
D/D |
6,500 |
32,370 |
0 |
- |
|
| RLAY |
Relay Therapeutics, Inc. |
General Counsel |
• – – |
2021-06-07 |
4 |
AS |
$35.00 |
$227,500 |
D/D |
(6,500) |
25,870 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
General Counsel |
• – – |
2021-06-28 |
4 |
S |
$35.81 |
$10,492 |
D/D |
(293) |
25,577 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
General Counsel |
• – – |
2021-09-13 |
4 |
OE |
$4.12 |
$26,780 |
D/D |
6,500 |
32,077 |
0 |
- |
|
| RLAY |
Relay Therapeutics, Inc. |
General Counsel |
• – – |
2021-09-13 |
4 |
AS |
$35.02 |
$227,630 |
D/D |
(6,500) |
25,577 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
General Counsel |
• – – |
2021-09-27 |
4 |
S |
$36.87 |
$10,803 |
D/D |
(293) |
25,284 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
General Counsel |
• – – |
2021-11-15 |
4 |
AS |
$35.42 |
$230,230 |
D/D |
(6,500) |
25,284 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
General Counsel |
• – – |
2021-11-15 |
4 |
OE |
$4.12 |
$26,780 |
D/D |
6,500 |
31,784 |
0 |
- |
|
| RLAY |
Relay Therapeutics, Inc. |
General Counsel |
• – – |
2021-12-27 |
4 |
S |
$33.10 |
$9,765 |
D/D |
(295) |
24,989 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
General Counsel |
• – – |
2021-12-31 |
4 |
A |
$26.10 |
$17,174 |
D/D |
658 |
25,647 |
0 |
- |
|
| RLAY |
Relay Therapeutics, Inc. |
Chief Legal Officer |
• – – |
2022-01-27 |
4 |
A |
$0.00 |
$0 |
D/D |
39,270 |
64,917 |
0 |
- |
|
| RLAY |
Relay Therapeutics, Inc. |
Chief Legal Officer |
• – – |
2022-03-29 |
4 |
S |
$29.87 |
$9,947 |
D/D |
(333) |
64,584 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
Chief Legal Officer |
• – – |
2022-04-28 |
4 |
S |
$25.57 |
$18,104 |
D/D |
(708) |
63,876 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
Chief Legal Officer |
• – – |
2022-06-27 |
4 |
S |
$20.31 |
$6,093 |
D/D |
(300) |
63,576 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
Chief Legal Officer |
• – – |
2022-07-28 |
4 |
S |
$21.27 |
$15,612 |
D/D |
(734) |
62,842 |
0 |
% |
|
68 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
